Boosting Resources for Tracheostomy Care at Home
Launched by MASSACHUSETTS GENERAL HOSPITAL · Feb 21, 2024
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The study is focused on a rare and medically complex population of children with tracheostomies. The study is a Type I hybrid effectiveness-implementation study using a pragmatic randomized trial at six participating sites. The goal of this trial is to advance the understanding of how to best support caregivers of children with tracheostomies who are caring for their child at home. The main question\[s\] it aims to answer are:
* What are the best ways to support caregivers post-discharge with both medical and nonmedical decisions about resuming life, work, and family activities, while safe...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Lead or primary adult caregiver (18 or older) of infants or children (0-17 years old) with tracheostomy who are planning for discharge to home, including children who are dependent on ventilator
- Exclusion Criteria:
- • Patients transferred to other hospital or facility (and/or not discharged to home during study period)
- • Primary caregiver unable to read or write in English, Spanish, Mandarin, or Arabic
- • Not residing in the U.S. for at least 12 months after discharge
About Massachusetts General Hospital
Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Cincinnati, Ohio, United States
Minneapolis, Minnesota, United States
Philadelphia, Pennsylvania, United States
La Jolla, California, United States
Silver Spring, Maryland, United States
Patients applied
Trial Officials
Karen Sepucha, PhD
Principal Investigator
Massachusetts General Hospital
Christopher Hartnick, MD
Principal Investigator
Massachusetts Eye and Ear Infirmary / Massachusetts General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported